SpringWorks Therapeutics Files 8-K: Material Agreement
| Field | Detail |
|---|---|
| Company | Springworks Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing-update
Related Tickers: SWTX
TL;DR
SWTX signed a big deal, 8-K filed 4/27. Details in exhibits.
AI Summary
On April 27, 2025, SpringWorks Therapeutics, Inc. entered into a material definitive agreement. The filing also includes information regarding Regulation FD disclosure and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Stamford, Connecticut.
Why It Matters
This 8-K filing indicates a significant new agreement for SpringWorks Therapeutics, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Players & Entities
- SpringWorks Therapeutics, Inc. (company) — Registrant
- April 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Stamford, Connecticut (location) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by SpringWorks Therapeutics, Inc. on April 27, 2025?
The filing does not specify the exact nature of the material definitive agreement, but it is listed as an 'Entry into a Material Definitive Agreement' under Item Information.
What other items are included in this 8-K filing?
This 8-K filing also includes 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.
Where are SpringWorks Therapeutics, Inc.'s principal executive offices located?
The principal executive offices of SpringWorks Therapeutics, Inc. are located at 100 Washington Blvd, Stamford, Connecticut 06902.
What is the company's fiscal year end?
The company's fiscal year ends on December 31 (1231).
What is the SIC code for SpringWorks Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for SpringWorks Therapeutics, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding SpringWorks Therapeutics, Inc..